|
1
|
de Martel C, Forman D and Plummer M:
Gastric cancer: Epidemiology and risk factors. Gastroenterol Clin
North Am. 42:219–240. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ohtsu A, Yoshida S and Saijo N:
Disparities in gastric cancer chemotherapy between the East and
West. J Clin Oneol. 24:2188–2196. 2006. View Article : Google Scholar
|
|
5
|
de Vries AC and Kuipers EJ: Epidemiology
of premalignant gastric lesions: Implications for the development
of screening and surveillance strategies. Helicobacter. 12 Suppl
2:S22–S31. 2007. View Article : Google Scholar
|
|
6
|
Kalluri R: Basement membranes: Structure,
assembly and role in tumour angiogenesis. Nat Rev Cancer.
3:422–433. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liotta LA and Kohn EC: The
microenvironment of the tumour-host interface. Nature. 411:375–379.
2001. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kessenbrock K, Plaks V and Werb Z: Matrix
metalloproteinases: Regulators of the tumor microenvironment. Cell.
141:52–67. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hua H, Li M, Luo T, Yin Y and Jiang Y:
Matrix metalloproteinases in tumorigenesis: An evolving paradigm.
Cell Mol Life Sci. 68:3853–3868. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Curran S and Morray GI: Matrix
metalloproteitases in tumour invasion and metastasis. J Pathol.
189:300–308. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zeng ZS, Cohen AM and Guillem JG: Loss of
basement membrane type IV collagen is associated with increased
expression of metalloproteinases 2 and 9 (MMP-2 and MMP-9) during
human colorectal tumorigenesis. Carcinogenesis. 20:749–755. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Heikinheimo K and Salo T: Expression of
basement membrane type IV collagen and type IV collagenases (MMP-2
and MMP-9) in human fetal teeth. J Dent Res. 74:1226–1234. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Roach DM, Fitridge RA, Laws PE, Millard
SH, Varelias A and Cowled PA: Up-regulation of MMP-2 and MMP-9
leads to degradation of type IV collagen during skeletal muscle
reperfusion injury; protection by the MMP inhibitor, doxycycline.
Eur J Vasc Endovasc Surg. 23:260–269. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhao Y, Zhou FL, Li WP, Wang J and Wang
LJ: Slit2-Robo1 signaling promotes the adhesion, invasion and
migration of tongue carcinoma cells via upregulating matrix
metalloproteinases 2 and 9 and downregulating E-cadherin. Mol Med
Rep. 14:1901–1906. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu C: Pathological and prognostic
significance of matrix metalloproteinase-2 expression in ovarian
cancer: A meta-analysis. Clin Exp Med. 16:375–382. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Pazzaglia L, Ponticelli F, Magagnoli G,
Magagnoli G, Gamberi G, Ragazzini P, Balladelli A, Picci P and
Benassi M: Activation of metalloproteinases-2 and −9 by
interleukin-1alpha in S100A4-positive liposarcoma cell line:
Correlation with cell invasiveness. Anticancer Res. 24:967–972.
2004.PubMed/NCBI
|
|
17
|
Hwang TL, Changchien TT, Wang CC and Wu
CM: Claudin-4 expression in gastric cancer cells enhances the
invasion and is associated with the increased level of matrix
metalloproteinase-2 and −9 expression. Oncol Lett. 8:1367–1371.
2014.PubMed/NCBI
|
|
18
|
Chen SJ, Yao XD, Peng BO, Xu YF, Wang GC,
Huang J, Liu M and Zheng JH: Epigallocatechin-3-gallate inhibits
migration and invasion of human renal carcinoma cells by
downregulating matrix metalloproteinase-2 and matrix
metalloproteinase-9. Exp Ther Med. 11:1243–1248. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sun W, Liu DB, Li WW, Zhang LL, Long GX,
Wang JF, Mei Q and Hu GQ: Interleukin-6 promotes the migration and
invasion of nasopharyngeal carcinoma cell lines and upregulates the
expression of MMP-2 and MMP-9. Int J Oncol. 44:1551–1560. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lee KR, Lee JS, Song JE, Ha SJ and Hong
EK: Inonotus obliquus-derived polysaccharide inhibits the migration
and invasion of human non-small cell lung carcinoma cells via
suppression of MMP-2 and MMP-9. Int J Oncol. 45:2533–2540. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Riley CM and Ren TC: Simple method for the
determination of paeonol in human and rabbit plasma by
high-performance liquid chromatography using solid-phase extraction
and ultraviolet detection. J Chromatogr. 489:432–437. 1989.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jiang SP and Chen YX: Advances in the
research and its clinical application of Cynanchum paniculatum
(Bge.) Kitag. Zhongguo Zhong Yao Za Zhi. 19:311–314. 1994.(In
Chinese). PubMed/NCBI
|
|
23
|
Anh Hle T, Cuc NT, Tai BH, Yen PH, Nhiem
NX, do T Thao, Nam NH, Van Minh C, Van Kiem P and Kim YH: Synthesis
of chromonylthiazolidines and their cytotoxicity to human cancer
cell lines. Molecules. 20:1151–1160. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xu SP, Sun GP, Shen YX, Wei W, Peng WR and
Wang H: Antiproliferation and apoptosis induction of paeonol in
HepG2 cells. World J Gastroenterol. 13:250–256. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li M, Tan SY and Wang XF: Paeonol exerts
an anticancer effect on human colorectal cancer cells through
inhibition of PGE2 synthesis and COX-2 expression. Oncol
Rep. 32:2845–2853. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yin J, Wu N, Zeng F, Cheng C, Kang K and
Yang H: Paeonol induces apoptosis in human ovarian cancer cells.
Acta Histochem. 115:835–839. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Horng CT, Shieh PC, Tan TW, Yang WH and
Tang CH: Paeonol suppresses chondrosarcoma metastasis through
up-regulation of miR-141 by modulating PKCδ and c-Src signaling
pathway. Int J Mol Sci. 15:11760–11772. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kim SA, Lee HJ, Ahn KS, Lee HJ, Lee EO,
Ahn KS, Choi SH, Jung SJ, Kim JY, Baek N and Kim SH: Paeonol exerts
anti-angiogenic and anti-metastatic activities through
downmodulation of Akt activation and inactivation of matrix
metalloproteinases. Biol Pharm Bull. 32:1142–1147. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Katakai M, Akamaru T and Tani T: An
analysis of appearance frequency of formulations and crude drugs in
Jin-Kui-Yao-Lue. Yakushigaku Zasshi. 38:1–10. 2003.(In Japanese).
PubMed/NCBI
|
|
30
|
Fan L, Song B, Sun G, Ma T, Zhong F and
Wei W: Endoplasmic reticulum stress-induced resistance to
doxorubicin is reversed by paeonol treatment in human
hepatocellular carcinoma cells. PLoS One. 8:e626272013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chou TC: Anti-inflammatory and analgesic
effects of paeonol in carrageenan-evoked thermal hyperalgesia. Br J
Pharmacol. 139:1146–1152. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xu SP, Sun GP, Shen YX, Peng WR, Wang H
and Wei W: Synergistic effect of combining paeonol and cisplatin on
apoptotic induction of human hepatoma cell lines. Acta Pharmacol
Sin. 28:869–878. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Cai J, Chen S, Zhang W, Hu S, Lu J, Xing J
and Dong Y: Paeonol reverses paclitaxel resistance in human breast
cancer cells by regulating the expression of transgelin 2.
Phytomedicine. 21:984–991. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li N, Fan LL, Sun GP, Wan XA, Wang ZG, Wu
Q and Wang H: Paeonol inhibits tumor growth in gastric cancer in
vitro and in vivo. World J Gastroenterol. 16:4483–4490. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hohenberger P and Gretschel S: Gastric
cancer. Lancet. 362:305–315. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Krejs GJ: Gastric cancer: Epidemiology and
risk factors. Dig Dis. 28:600–603. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Parsons SL, Watson SA, Collins HM, Griffin
NR, Clarke PA and Steele RJ: Gelatinase (MMP-2 and −9) expression
in gastrointestinal malignancy. Br J Cancer. 78:1495–1502. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lim SC: Expression of matrix
metalloproteinases and its inhibitor in gastric adenocarcinoma.
Cancer Res Treat. 33:199–206. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Noh S, Jung JJ, Jung M, Kim TS, Park CH,
Lim SJ, Jeung HC, Cheol H, Chung HC and Rha SY: MMP-2 as a putative
biomarker for carcinomatosis in gastric cancer.
Hepatogastroenterology. 58:2015–2019. 2011. View Article : Google Scholar : PubMed/NCBI
|
